Results 221 to 230 of about 451,989 (311)

Association Between Lower Serum Mitsugumin 53 Levels and the Risk of Vascular Calcification in Hemodialysis Patients. [PDF]

Int J Nephrol Renovasc Dis
Ren W, Liu C, Yan Y, Han M, Xiang P, Pang Q, Zhang A.   +6 more
europepmc   +1 more source

Role of interstitial inflammation in the pathogenesis of polycystic kidney disease

Nephrology, 2013
Michelle HT Ta, D. Harris, G. Rangan
semanticscholar   +1 more source

Baseline comorbidity of cardiovascular-kidney-metabolic syndrome increases the risk of adverse clinical outcomes in patients with chronic kidney disease. [PDF]

Front Endocrinol (Lausanne)
Meng J, Li W, Fu W, Zhang A.
europepmc   +1 more source

Functional Defects in Lysosomal Enzymes in Autosomal Dominant Polycystic Kidney Disease (ADPKD): Abnormalities in Synthesis, Molecular Processing, Polarity, and Secretion

, 1997
Patricia A. Hartz, Patricia D. Wilson
openalex   +1 more source

Simultaneous Bilateral Pediatric Nephrectomies: Indications, Approach and Outcomes Over a 15-Year Period. [PDF]

Pediatr Transplant
Lombardo AM, Stout M, Zann A, McLeod D, Alpert S, Jayanthi VR, DaJusta D, Ching CB.   +7 more
europepmc   +1 more source

FK 506 in the management of nephrotic syndrome after renal transplantation [PDF]

, 1993
Jensen, C, Jordan, M, McCauley, J, Scantlebury, V, Shapiro, R, Starzl, TE, Vivas, C   +6 more
core  

Renalase, dopamine, and norepinephrine as markers for the development of hypertension in CKD patients. [PDF]

BMC Nephrol
Heryć R, Cecerska-Heryć E, Serwin N, Stodolak P, Goszka M, Polikowska A, Ciechanowski K, Wiśniewska M.   +7 more
europepmc   +1 more source

Sirtuins and Resveratrol in Cardiorenal Diseases: A Narrative Review of Mechanisms and Therapeutic Potential. [PDF]

Nutrients
Carollo C, Sorce A, Cirafici E, Mulè G, Caimi G.   +4 more
europepmc   +1 more source

GANAB-Associated Severe Autosomal Dominant Polycystic Kidney Disease in an 18-Year-Old Female: A Case Report. [PDF]

Cureus
Agrawal G, Agarwal B, Chandrasekhara Pillai A, Kuriakose K.   +3 more
europepmc   +1 more source

Bone mineral density and microarchitecture improvement in a young patient with Hajdu-Cheney syndrome and autosomal dominant polycystic kidney disease treated with alendronate. [PDF]

Bone Rep
Franco AS, Caparbo VF, Watanabe EH, Pereira RMR, Onuchic LF.   +4 more
europepmc   +1 more source